STOCKHOLDERS’ DEFICIENCY (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended		12 Months Ended
	May 22, 2020	Feb. 02, 2016	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021	Mar. 30, 2021	Mar. 31, 2020	Mar. 30, 2020	Mar. 31, 2019	Mar. 31, 2018
Class of Stock [Line Items]
Common stock, shares authorized				125,000,000		125,000,000
Common Stock, Par or Stated Value Per Share						$ 0.001
Preferred Stock, Shares Authorized				10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001
Common Stock, Shares, Outstanding				37,850,064		36,124,964
Common Stock, Shares, Issued						36,124,964
Common Stock, Other Shares, Outstanding				1,466,718		2,889,978
Preferred Stock, Shares Outstanding				1
Number of stock issued during the period convertible, shares				183,202			733,085
Number of common shares issued, value					$ 215,000
Number of common stock compensation for services						1,900,042
Stock price			$ 0.76					$ 0.76		$ 0.588
Number of options granted				170,532		2,610,647		88,100		270,521	4,147,498
Stock based compensation				$ 155,851	$ 232,519
Additional Paid in Capital				$ 57,192,182		$ 56,298,726
2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Plan description		The maximum number of shares of stock that may be issued under the Plan shall be equal to 3,750,000 shares; provided that the maximum number of shares of stock that may be issued under the Plan pursuant to awards shall automatically and without any further Company or shareholder approval, increase on January 1 of each year for not more than 10 years from the effective date, so the number of shares that may be issued is an amount no greater than 20% of the Company’s outstanding shares of stock and shares of stock underlying any outstanding exchangeable shares as of such January 1; provided further that no such increase shall be effective if it would violate any applicable law or stock exchange rule or regulation, or result in adverse tax consequences to the Company or any participant that would not otherwise result but for the increase.
Number of options authorized to issue		3,750,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term				9 years 3 months 18 days				8 years 8 months 12 days
Stock price			$ 0.974					$ 0.974
Number of options granted				170,532		2,610,647
Stock based compensation				$ 155,851		$ 790,535
2016 Equity Incentive Plan [Member] | General and Administrative Expense [Member]
Class of Stock [Line Items]
Additional Paid in Capital				$ 232,519
Minimum [Member]
Class of Stock [Line Items]
Expected life				2 years		2 years		2 years		2 years
Stock price				$ 0.59		$ 0.72
Minimum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Expected life			3 years
Risk free rate			0.46%
Maximum [Member]
Class of Stock [Line Items]
Expected life				10 years		10 years		3 years		3 years
Stock price				$ 2.14		$ 1.72
Maximum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Expected life			10 years
Risk free rate			0.75%
Convertible Notes [Member]
Class of Stock [Line Items]
Number of shares issued				18,402
Debt settlement amount				$ 1,190,502		$ 38,460
Convertible promissory notes				1,157,500		739,000
Conversion redemption feature amount				403,108		225,284
Unpaid interest amount				81,441		47,002
Conversion of stock				$ 479,760		$ 1,076,561
Stock Issued During Period, Shares, Conversion of Convertible Securities				345,676
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value				$ 1,190,502
Number of warrants exercised				55,493
One Warrant Holder [Member]
Class of Stock [Line Items]
Number of warrants exercised				37,736
Warrant [Member]
Class of Stock [Line Items]
Number of warrants exercised						97,500
Cash receipt amount						$ 67,941
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares authorized				1,423,260		898,084
Number of shares issued
Number of common shares issued, value
Stock Issued During Period, Shares, Conversion of Convertible Securities				201,604
Common Stock [Member] | Convertible Notes [Member]
Class of Stock [Line Items]
Number of common shares issued, value				$ 28,213		$ 103,375
Issuance of Common Shares [Member] | Advisor [Member]
Class of Stock [Line Items]
Number of shares issued				345,676		18,402
Debt settlement amount				$ 1,642,049		$ 1,011,286
Advisor and Consultant [Member] | Warrant [Member]
Class of Stock [Line Items]
Number of common stock compensation for services				60,000		449,583
Number of common stock compensation for services, value						$ 275,801
Warrants issued				50,000
Fair value of warrants				$ 151,897
Advisor and Consultant [Member] | Warrant [Member] | Minimum [Member]
Class of Stock [Line Items]
Expected life								3 years
Advisor and Consultant [Member] | Warrant [Member] | Maximum [Member]
Class of Stock [Line Items]
Expected life								10 years
Advisor and Consultant [Member] | Warrant [Member] | Convertible Notes [Member]
Class of Stock [Line Items]
Number of warrants exercised				100,236
Stock Issued During Period, Value, Stock Options Exercised				$ 106,250
Chief Financial Officer [Member] | Warrant [Member]
Class of Stock [Line Items]
Warrants issued						788,806		288,806
Fair value of warrants						$ 464,971
Brokers [Member] | Warrant [Member]
Class of Stock [Line Items]
Number of warrants exercised						1,065,857
Convertible Noteholders [Member] | Warrant [Member]
Class of Stock [Line Items]
Number of warrants exercised						5,631,132
One Warrant Holder [Member]
Class of Stock [Line Items]
Number of warrants exercised				37,736
Proceeds from warrants				$ 40,000
Shares to be issued during the period for warrant exercise				37,736
Board of Director [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Number of common stock compensation for services, value								$ 1,600,515
Expected life								10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term								10 years
Expected volatility								132.20%
Exchange Agreement [Member] | 11% Secured Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Conversion description				The outstanding 11% secured convertible promissory notes of iMedical were adjusted, in accordance with the adjustment provisions thereof, as and from closing, so as to permit the holders to convert (and in some circumstances permit the Company to force the conversion of) the convertible promissory notes into shares of the common stock of the Company at a 25% discount to purchase price per share in Biotricity’s next offering
Discount percentage for purchase price per shares				25.00%
Exchange Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 shares of the common stock of the Company for each warrant, with an inverse adjustment to the exercise price of the warrants to reflect the exchange ratio of approximately 1.197:1
Exchange Agreement [Member] | Advisor Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description						1.197 shares of the common stock of the Company for each advisor warrant, with an inverse adjustment to the exercise price of the Advisor Warrants to reflect the exchange ratio of approximately 1.197:1;
Exchange Agreement [Member] | Options [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 economically equivalent replacement options with an inverse adjustment to the exercise price of the replacement option to reflect the exchange ratio of approximately 1.197:1;
Exchange Agreement [Member] | Shareholders [Member]
Class of Stock [Line Items]
Number of shares issued				39,316,782		39,014,942
Common stock exchange description				1.197 shares of its common stock in exchange for each common share of iMedical held by the iMedical shareholders who in general terms, are not residents of Canada
Exchange Agreement [Member] | Exchangeco [Member]
Class of Stock [Line Items]
Common stock exchange description				1.197 Exchangeable Shares in the capital of Exchangeco in exchange for each common share of iMedical held.
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized				20,000		20,000
Preferred Stock, Par or Stated Value Per Share			$ 0.001	$ 0.001		$ 0.001		$ 0.001
Number of shares issued	100			6,000
Preferred Stock, Shares Outstanding				8,045		8,045
Accrued preferred stock dividends							$ 962,148		$ 257,927
Dividends paid							$ 602,969		$ 180,000